In this episode, Dr. Matthew Weiner and Zoë discuss their predictions for weight loss trends in 2024, including the rise of ZepBound over Ozempic, the ongoing debate between plant-based and keto diets, and the challenges of insurance coverage for GLP-1 medications. They also explore the increasing role of AI in weight loss management and the future of compounded medications in the healthcare landscape. In this conversation, Zoë and Dr. Matthew Weiner discuss the complexities of weight loss, the evolving landscape of fitness trends, and the integration of GLP-1 medications with bariatric surgery as a new standard for obesity treatment. They explore the societal shifts in caffeine and alcohol consumption, the potential of AI in meal planning, and the future of dietary products related to GLP-1s. The discussion emphasizes the importance of individualized approaches to health and nutrition, while also addressing the challenges and expectations surrounding weight loss treatments.

Learn more about our Pound of Cure Platinum Program here.